Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Autor: The Rosen Law Firm, P.A.
Zdroj: Business Wire (English). 12/13/2024.
Abstrakt: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between February 7, 2024 and November 24, 2024. Cassava describes itself as a “clinical stage biotechnology company, with a focus on developing drugs for neurodegenerative diseases.” [ABSTRACT FROM PUBLISHER]
Databáze: Regional Business News
Nepřihlášeným uživatelům se plný text nezobrazuje